Source:http://linkedlifedata.com/resource/pubmed/id/15039538
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 4
|
pubmed:dateCreated |
2004-3-24
|
pubmed:abstractText |
The non-structural protein 5A (NS5A) of hepatitis C virus (HCV) has been implicated in inhibition of antiviral activity of IFN. While previous studies have suggested an interaction between NS5A and the double-stranded RNA-dependent protein kinase (PKR), the possibility still remains that interaction with another molecule(s) is involved in the NS5A-mediated inhibition of IFN. In the present study, we investigated a possible interaction between NS5A and 2',5'-oligoadenylate synthetase (2-5AS), another key molecule in antiviral activity. We observed that NS5A physically interacted with 2-5AS in cultured cells, with an N-terminal portion of NS5A [aa 1-148; NS5A(1-148)] and two separate portions of 2-5AS (aa 52-104 and 184-275) being involved in the interaction. Single point mutations at residue 37 of NS5A affected the degree of the interaction with 2-5AS, with a Phe-to-Leu mutation (F37L) augmenting and a Phe-to-Asn mutation (F37N) diminishing it. Virus rescue assay revealed that the full-length NS5A (NS5A-F) and NS5A(1-148), the latter of which contains neither the IFN sensitivity-determining region (ISDR) nor the PKR-binding domain, significantly counteracted the antiviral activity of IFN. Introduction of a F37N mutation into NS5A(1-148) impaired the otherwise more significant IFN-inhibitory activity of NS5A(1-148). It was also found that the F37N mutation was highly disadvantageous for the replication of an HCV RNA replicon. Taken together, our results suggest the possibility that NS5A interacts with 2-5AS and inhibits the antiviral activity of IFN in an ISDR-independent manner.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2',5'-Oligoadenylate Synthetase,
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/NS-5 protein, hepatitis C virus,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Nonstructural Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-1317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
959-69
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15039538-2',5'-Oligoadenylate Synthetase,
pubmed-meshheading:15039538-Animals,
pubmed-meshheading:15039538-Base Sequence,
pubmed-meshheading:15039538-Cell Line,
pubmed-meshheading:15039538-DNA, Viral,
pubmed-meshheading:15039538-HeLa Cells,
pubmed-meshheading:15039538-Hepacivirus,
pubmed-meshheading:15039538-Humans,
pubmed-meshheading:15039538-Interferon-alpha,
pubmed-meshheading:15039538-Mice,
pubmed-meshheading:15039538-Mutagenesis, Site-Directed,
pubmed-meshheading:15039538-Recombinant Fusion Proteins,
pubmed-meshheading:15039538-Recombinant Proteins,
pubmed-meshheading:15039538-Sequence Deletion,
pubmed-meshheading:15039538-Transfection,
pubmed-meshheading:15039538-Viral Nonstructural Proteins
|
pubmed:year |
2004
|
pubmed:articleTitle |
Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner.
|
pubmed:affiliation |
Division of Microbiology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|